Pharmaceutical Technologist - September 2007 - (Page 29)

// Beauchamp which can efficiently print 2D barcode labels in realtime, ensuring that no delays are incurred in the process. This new ability to easily manage a variety of media means an end to ‘spaghetti-like’ jams, reducing wasted labels, time and money. Conclusion With regulations now being enforced for the clear and accurate labelling of pharmaceuticals, manufacturers and packaging companies cannot afford to produce difficult-to-read or badly designed labels, or to incur delays in time-to-market because of poorly labelled products. Likewise, wasting valuable time manually adjusting and solving problems with conventional printers is a headache that can now be avoided as the new generation of label printers enable compliance to be met with increased efficiency and output levels. Meeting compliance with labelling legislation is a topic that isn’t going to go away; if anything, it is likely that regulations will become tighter with time, making an investment valuable in both the long- and short-term. PT Hovione’s Particle Design technologies can transform an old generic product into a dynamic new drug. Hovione combines 50 years’ experience in API process development and compliant manufacturing with unique expertise in Particle Design and cGMP spray drying. Whether you are interested in the reliable supply of value generics or enhancing the performance of your API or drug product, our promise is quality on-time. To find out more visit us at www.hovione.com or call us now on Worldwide +351 21 982 9451, or North America +1 609 918 2466 Reference 1. www.mhra.gov.uk/home/groups/ comms-ic/documents/publication/ con007558.pdf Mark Beauchamp is European marketing manager for Citizen Systems Europe (UK). He has a total of 18 years’ experience with the company and currently looks after all aspects of Citizen’s marketing within Europe, the Middle East and Africa including PR, marcoms, product marketing, product management and new product introductions. Active anticipation, assured results. Exclusives Inhalation Particle Design Generics www.ptemagazine.com 29 http://www.mhra.gov.uk/home/groups/comms-ic/documents/publication/con007558.pdf http://www.hovione.com http://www.hovione.com http://www.ptemagazine.com

Table of Contents Feed for the Digital Edition of Pharmaceutical Technologist - September 2007

Contents Editor’s Comment News Morpheus Market Watch CPhI Worldwide 2007 Compliant Pharmaceutical Labelling Q&A

Pharmaceutical Technologist - September 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.